• A transition from purely descriptive tumor pathology to cellular and molecular cancer biology, employing in vitro assays and labeling to quantify growth, proliferation, and drug responses (e.g., tritiated thymidine labeling and autoradiography) [9], [10], [11], [12], [14].

• Antigenicity and immune interactions between host and tumor emerged as a core theme, with studies on chemical‑induced tumor antigens and host differences in isologous systems, hinting at antigen processing and immune recognition in cancer [2], [13], [19].

• Patterns of tumor dissemination and metastasis were investigated through models of intravenous tumor cell fate, emboli transport, and organ‑level spread, linking vascular access to metastatic potential [3], [4], [6], [7], [18].

• Pathology, prognosis, and tumor classification informed by morphology and outcomes, aligning histopathology with recurrence and survival cues through focused organ and tumor type studies [1], [15], [17], [20].

• Chemical carcinogenesis and induced tumor models provided experimental frameworks for carcinogen exposure, tumor induction, and modulators of malignancy [2], [9], [16], [19].